Wordt geladen...
Biomarker development in the precision medicine era: lung cancer as a case study
Precision medicine relies on validated biomarkers with which to better classify patients by their probable disease risk, prognosis and/or response to treatment. Although affordable ‘omics’-based technology has enabled faster identification of putative biomarkers, the validation of biomarkers is stil...
Bewaard in:
| Gepubliceerd in: | Nat Rev Cancer |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6662593/ https://ncbi.nlm.nih.gov/pubmed/27388699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrc.2016.56 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|